Market Place
Sourcing Support
Delaware Court Backs Zantac Drugmakers in Cancer Lawsuits
12 Jul 2025 //
REUTERS
EU Commission fines pharma companies for price fixing
19 Oct 2023 //
REUTERS
Lupin wins first FDA approval for generic version of blockbuster Spiriva
22 Jun 2023 //
ENDPTS
CHMP Recommends One New Drug, Begins Review of Indian CRO
29 Feb 2020 //
RAPS
Digital Dose Inhalers Market-Opportunities With AstraZeneca, Novartis,Technavio
20 Sep 2019 //
BUSINESSWIRE
Spiriva (Tiotropium bromide): Boehringer Ingelheim vs. Lupin
02 Dec 2018 //
PATENT LITIGATION
GLYXAMBI (empagliflozin/linagliptin) : Boehringer Ingelheim vs. Prinston Pharms
25 Nov 2018 //
PATENT LITIGATION
Daliresp (Roflumilast) : AstraZeneca vs. Alkem
24 Nov 2018 //
PATENT LITIGATION
Jardiance (empagliflozin) : Boehringer Ingelheim vs. Laurus Labs
24 Nov 2018 //
PATENT LITIGATION
Jardiance (empagliflozin) : Boehringer Ingelheim vs. Macleods Pharms
20 Nov 2018 //
PATENT LITIGATION
Jardiance (empagliflozin) & Glyxambi (empagliflozin/linagliptin) : Boehringer Ingelheim vs. Alkem Laboratories
07 Nov 2018 //
PATENT LITIGATION
AMITIZA® (lubiprostone) : Sucampo Pharmaceuticals vs. Sun Pharmaceutical
31 Oct 2018 //
PATENT LITIGATION
Battle Over Humira Begins in Europe as 5-Year Wait Begins in US
22 Oct 2018 //
RAPS
Drugmakers Call for Changes, Additions to FDA’s Purple Book
27 Sep 2018 //
RAPS
Spiriva (Tiotropium bromide) : Boehringer Ingelheim Pharmaceuticals v. Lupin Ltd
13 Aug 2018 //
PATENT LITIGATION
Express Scripts bars 48 drugs for 2019, hitting AbbVie, Gilead, Boehringer
08 Aug 2018 //
FIERCE PHARMA
GILOTRIF® (afatinib): Boehringer Ingelheim et al v. Apotex Inc. et al
04 Jul 2018 //
PATENT LITIGATION
Ingelvac Circoflex® : Boehringer Ingelheim v. Intervet, Merck Animal Health
21 May 2018 //
PATENT LITIGATION
New Hikma CEO Olafsson gets to work on 200 more generics layoffs
17 Mar 2018 //
FIERCE PHARMA
Gilotrif® (Afatinib): Boehringer Ingelheim Pharmaceuticals v. Fresenius Kabi USA
07 Feb 2018 //
PATENT LITIGATION
Novartis joins biosimilar Humira push in US
16 Jan 2018 //
PMLIVE
HUMIRA® REMICADE® (adalimumab ; infliximab): AbbVie Inc. et al v. Boehringer Ingelheim International GMBH
02 Aug 2017 //
PATENT LITIGATION
Trouble at the top of Stada as Bain and Cinven mull fresh bid
07 Jul 2017 //
PMLIVE
Sanofi Looking to Slap `For Sale` Sign on Its EU Generic Drug, Deal $2.1 Billion
08 Mar 2017 //
BIOSPACE
Sanofi having difficulty deciding how, or even if, to divest EU generics biz
02 Mar 2016 //
FIERCE PHARMA
Despite Generic Erosion of Current Market, Asthma Market Will Remain Steady
22 Sep 2015 //
PR NEWS WIRE
Lilly and Boehringer launch Lantus biosimilar in UK
26 Aug 2015 //
PM LIVE
Hikma to buy Boehringer`s U.S. generics unit for $2.65 billion
29 Jul 2015 //
REUTERS
Court lets Boehringer, Teva take Aggrenox case to 2nd Circuit
23 Jul 2015 //
REUTERS
Spanish sterile injectable player gets snapped up
16 Jun 2015 //
FIERCE PHARMA MANUFACTURING
Will Mylan`s $29B Bid Spur Other Perrigo Suitors To Enter The Fray?
10 Apr 2015 //
FIERCE PHARMA
German Firm Boehringer Ingelheim’s Patent for Asthma Drug Revoked
10 Mar 2015 //
THE ECONOMIC TIMES
